Results 171 to 180 of about 10,488 (236)
[Aumolertinib combined with anlotinib inhibits proliferation of non-small cell lung cancer cells by down-regulating the PI3K/AKT pathway]. [PDF]
Yang Y +9 more
europepmc +1 more source
[Advances in Pseudoprogression of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer]. [PDF]
Tong Y, Long Y, Zhang F, Li J.
europepmc +1 more source
Alectinib treatment for 2 non-small cell lung carcinoma patients carrying different novel ALK fusions. [PDF]
Liang Q, Li N, Li X.
europepmc +1 more source
[Research Progress on Predictive Biomarkers of Immunotherapy Efficacy in Non-small Cell Lung Cancer]. [PDF]
Sun T, Chen Z, Wei K, Tang H.
europepmc +1 more source
[Non-small Cell Lung Cancer with Metachronous Mutations of EGFR and ALK Genes: A Case Report and Literature Review]. [PDF]
Kong X, Wang M, Tang Q, Sun M, Hu J.
europepmc +1 more source

